Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial. [electronic resource]
Producer: 20151009Description: 8-17 p. digitalISSN:- 1423-0267
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Blood Viscosity
- Female
- Fluorescein Angiography
- Hemodilution -- methods
- Humans
- Intravitreal Injections
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Ranibizumab
- Retinal Vein Occlusion -- complications
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.